Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $2.96B | $4.40B | – | – | $2.97B |
| Total Operating Revenue | $2.96B | $4.40B | $12.19B | $3.34B | $2.97B |
| Cost of Revenue | $2.17B | $1.59B | $5.99B | $1.57B | $1.52B |
| Gross Profit | $787.00M | $2.81B | $6.20B | $1.77B | $1.45B |
| Operating Expense | $66.00M | $1.21B | $3.43B | $873.00M | $670.00M |
| Selling and Admin Expenses | $50.00M | $1.18B | $3.34B | $840.00M | $704.00M |
| -General & Admin Expense | $50.00M | $63.00M | $181.00M | $49.00M | $45.00M |
| Other Operating Expenses | $16.00M | $27.00M | $86.00M | $33.00M | -$34.00M |
| Operating Profit | $721.00M | $1.60B | $2.77B | $898.00M | $779.00M |
| Net Non-Operating Interest Income (Expense) | -$43.00M | -$59.00M | -$235.00M | -$59.00M | -$57.00M |
| Non-Operating Interest Expense | $43.00M | $59.00M | $235.00M | $59.00M | $57.00M |
| Other Income (Expense) | -$6.00M | -$53.00M | -$254.00M | -$152.00M | -$36.00M |
| Special Income (Charges) | -$23.00M | -$70.00M | -$296.00M | -$153.00M | -$53.00M |
| -Less:Restructuring and Mergern & Acquisition | $60.00M | $69.00M | $198.00M | $48.00M | $53.00M |
| -Less:Other Special Charges | -$37.00M | – | -$4.00M | $0.00 | -$1.00M |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | -$1.00M | -$65.00M | -$68.00M | -$1.00M |
| Other Non-Operating Income (Expenses) | $17.00M | $17.00M | $42.00M | $1.00M | $17.00M |
| Pretax Profit | $672.00M | $1.49B | $2.28B | $687.00M | $686.00M |
| Tax | $150.00M | $330.00M | $463.00M | $134.00M | $139.00M |
| Net Profit | $522.00M | $1.16B | $1.82B | $553.00M | $547.00M |
| Profit from Continuing Operations | $522.00M | $1.16B | $1.82B | $553.00M | $547.00M |
| Net Income to Parent Company | $522.00M | $1.16B | $1.82B | $553.00M | $547.00M |
| Net Income to Common Stockholders | $522.00M | $1.16B | $1.82B | $553.00M | $547.00M |
| Basic EPS | $2.19 | $4.83 | $7.67 | $2.32 | $2.30 |
| Diluted EPS | $2.19 | $4.81 | $7.57 | $2.30 | $2.28 |
| Dividend Per Share | $0.58 | $0.58 | $3.19 | $0.58 | $1.47 |
| -Selling & Marketing Expense | – | $1.12B | $3.16B | $791.00M | $659.00M |
| -Less:Impairment of Capital Assets | – | – | $37.00M | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $28.03B | $29.52B | $28.29B | $28.29B | $27.61B |
| Total Current Assets | $2.84B | $4.39B | $2.92B | $2.92B | $2.24B |
| Cash and Cash Equivalents & Short-Term Investments | $663.00M | $2.22B | $616.00M | $616.00M | $613.00M |
| -Cash and Cash Equivalents | $663.00M | $2.22B | $616.00M | $616.00M | $613.00M |
| Receivables | $1.10B | $1.29B | $1.60B | $1.60B | $1.03B |
| -Accounts Receivable | $857.00M | $957.00M | $1.36B | $1.36B | $743.00M |
| -Due from Related Parties Current | $254.00M | $255.00M | $232.00M | $232.00M | $258.00M |
| -Other Receivables | $1.00M | $92.00M | $18.00M | $18.00M | $38.00M |
| -Receivables Adjustments Allowances | -$14.00M | -$14.00M | -$14.00M | -$14.00M | -$13.00M |
| Restricted Cash | $101.00M | $85.00M | $80.00M | $80.00M | $78.00M |
| Other Current Assets | $378.00M | $363.00M | $357.00M | $357.00M | $367.00M |
| Total Non-Current Assets | $25.19B | $25.13B | $25.37B | $25.37B | $25.37B |
| Net PPE | $24.45B | $24.32B | $24.32B | $24.32B | $24.24B |
| -Gross PPE | $34.14B | $33.29B | $32.59B | $32.59B | $31.80B |
| -Accumulated Depreciation | -$9.69B | -$8.98B | -$8.28B | -$8.28B | -$7.56B |
| Financial Assets | $113.00M | $127.00M | $47.00M | $47.00M | $10.00M |
| Non-Current Deferred Assets | $0.00 | $0.00 | $168.00M | $168.00M | $273.00M |
| Other Non-Current Assets | $625.00M | $692.00M | $841.00M | $841.00M | $846.00M |
| Total Liabilities | $8.62B | $9.98B | $9.71B | $9.71B | $9.46B |
| Total Current Liabilities | $2.97B | $3.95B | $2.90B | $2.90B | $2.77B |
| Payables | $2.00B | $2.18B | $1.88B | $1.88B | $1.81B |
| -Accounts Payable | $942.00M | $881.00M | $753.00M | $753.00M | $830.00M |
| -Total Tax Payable | $185.00M | $146.00M | $157.00M | $157.00M | $169.00M |
| -Other Payable | $875.00M | $1.16B | $972.00M | $972.00M | $808.00M |
| Current Accrued Expenses | $455.00M | $391.00M | $450.00M | $450.00M | $424.00M |
| Short-Term Debt and Capital Lease Obligation | $43.00M | $926.00M | $51.00M | $51.00M | $63.00M |
| -Current Capital Lease Obligation | $43.00M | $51.00M | $51.00M | $51.00M | $63.00M |
| Current Deferred Liabilities | $265.00M | $262.00M | $264.00M | $264.00M | $271.00M |
| Other Current Liabilities | $133.00M | $133.00M | $147.00M | $147.00M | $117.00M |
| Total Non-Current Liabilities | $5.66B | $6.03B | $6.81B | $6.81B | $6.69B |
| Long Term Debt and Capital Lease Obligation | $3.69B | $4.13B | $5.01B | $5.01B | $5.01B |
| -Long Term Debt | $3.69B | $4.13B | $5.01B | $5.01B | $5.01B |
| Derivative Product Liabilities | $0.00 | $0.00 | $1.00M | $1.00M | $27.00M |
| Non-Current Liabilities | $723.00M | $703.00M | $688.00M | $688.00M | $525.00M |
| Non-Current Deferred Liabilities | $835.00M | $911.00M | $975.00M | $975.00M | $1.03B |
| Other Non-Current Liabilities | $412.00M | $278.00M | $135.00M | $135.00M | $101.00M |
| Total Equity | $19.41B | $19.55B | $18.58B | $18.58B | $18.15B |
| Stockholders' Equity | $19.41B | $19.55B | $18.58B | $18.58B | $18.15B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Additional Paid-In Capital | $13.77B | $13.76B | $13.75B | $13.75B | $13.73B |
| Retained Earnings | $5.63B | $5.79B | $4.83B | $4.83B | $4.42B |
| -Current Debt | – | $875.00M | – | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.10B | $2.40B | $4.58B | $956.00M | $1.20B |
| Net cash flow from continuing operations | $1.10B | $2.40B | $4.58B | $956.00M | $1.20B |
| Net Income from Continuing Operations | $522.00M | $1.16B | $1.82B | $553.00M | $547.00M |
| Gain/Loss from Continuing Operations | -$486.00M | $130.00M | -$489.00M | -$168.00M | -$451.00M |
| Depreciation & Depletion & Amortization | $722.00M | $711.00M | $2.98B | $759.00M | $741.00M |
| Deferred Tax | $146.00M | $319.00M | $448.00M | $128.00M | $186.00M |
| Other Non-Cash Items | $225.00M | -$381.00M | $56.00M | $99.00M | $94.00M |
| Change in Working Capital | -$45.00M | $454.00M | -$285.00M | -$427.00M | $72.00M |
| Net cash flow from investing | -$698.00M | -$601.00M | -$2.76B | -$816.00M | -$845.00M |
| Net Cash Flow from Continuing Investing Activities | -$698.00M | -$601.00M | -$2.76B | -$816.00M | -$845.00M |
| Capital Expenditure | -$753.00M | -$707.00M | -$2.74B | -$741.00M | -$775.00M |
| Net PPE Purchase and Sale | -$1.00M | $37.00M | -$125.00M | -$75.00M | -$65.00M |
| Net Investment Purchase and Sale | -$10.00M | $9.00M | -$14.00M | $0.00 | -$5.00M |
| Net Other Investing Changes | $56.00M | $60.00M | $116.00M | $0.00 | $0.00 |
| Financing Cash Flow | -$1.94B | -$192.00M | -$1.52B | -$135.00M | -$471.00M |
| Net Cash Flow from Continuing Financing Activities | -$1.94B | -$192.00M | -$1.52B | -$135.00M | -$471.00M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | -$663.00M | -$663.00M | $0.00 |
| Net Common Stock Issuance | -$514.00M | -$66.00M | -$100.00M | $0.00 | -$1.00M |
| Cash Dividends Paid | -$138.00M | -$141.00M | -$765.00M | -$137.00M | -$349.00M |
| Proceeds from Stock Option Exercised | $0.00 | $15.00M | $24.00M | $2.00M | $0.00 |
| Ending Cash Balance | $764.00M | $2.31B | $696.00M | $696.00M | $691.00M |
| Net Change in Cash | -$1.54B | $1.61B | $301.00M | $5.00M | -$115.00M |
| Beginning Cash Balance | $2.31B | $696.00M | $395.00M | $691.00M | $806.00M |
| Free Cash Flow | $340.00M | $1.69B | $1.64B | $89.00M | $357.00M |
| Net Business Purchase and Sale | – | – | $0.00 | – | – |
| Net Other Financing Charges | – | – | -$11.00M | $663.00M | -$121.00M |
No comments yet — be the first to weigh in on EXE.